Evidence map›Paper›PMID 33417227›Full record

ArticleMolecular neurobiology2021

Phosphoenolpyruvate Carboxykinase (PCK) in the Brain Gluconeogenic Pathway Contributes to Oxidative and Lactic Injury After Stroke.

Xiaokun Geng, Jiamei Shen, Fengwu Li, James Yip, Longfei Guan, Gary Rajah, Changya Peng, Donald DeGracia, Yuchuan Ding

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular neurobiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Changes in the brain [NADFrontiers in aging neuroscience · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Xiaokun Geng *China-America Institute of Neuroscience, Beijing Luhe Hospital, Capital Medical University, Beijing, China. xgeng@ccmu.edu.cn.
Jiamei Shen *China-America Institute of Neuroscience, Beijing Luhe Hospital, Capital Medical University, Beijing, China.
Fengwu LiChina-America Institute of Neuroscience, Beijing Luhe Hospital, Capital Medical University, Beijing, China.
James YipDepartment of Pathology, John A. Burns School of Medicine, University of Hawaii, Honolulu, HI, USA.
Longfei GuanChina-America Institute of Neuroscience, Beijing Luhe Hospital, Capital Medical University, Beijing, China.
Gary RajahDepartment of Neurosurgery, Wayne State University School of Medicine, Detroit, MI, 48201, USA.
Changya PengDepartment of Neurosurgery, Wayne State University School of Medicine, Detroit, MI, 48201, USA.
Donald DeGraciaCenter for Molecular Medicine and Genetics, Wayne State University School of Medicine, Detroit, MI, USA.
Yuchuan DingDepartment of Neurosurgery, Wayne State University School of Medicine, Detroit, MI, 48201, USA. yding@med.wayne.edu.ORCID http://orcid.org/0000-0001-5358-1660
Wayne State University · USBeijing Luhe Hospital Affiliated to Capital Medical University · CNMunson Medical Center · USUniversity of Hawaiʻi at Mānoa · US

Funding

Merit Review Award I01RX-001964-01National Natural Science Foundation of China 81871838
6 · The paper itself

Abstract

To demonstrate the role of the rate-limiting and ATP-dependent gluconeogenic enzyme phosphoenolpyruvate carboxykinase (PCK) in oxidative and lactic stress and the effect of phenothiazine on PCK after stroke, a total of 168 adult male Sprague Dawley rats (3 months old, 280-300 g) underwent 2-h intraluminal middle cerebral artery occlusion (MCAO) and reperfusion for 6, 24, 48 h, or 7 days. Phenothiazine (chlorpromazine and promethazine (C+P)) (8 mg/kg) and 3-mercaptopicolinic acid (3-MPA, a PCK inhibitor, 100 μM) were administered at reperfusion onset. The effects of phosphoenolpyruvate, 3-MPA, or PCK knockdown were studied in neuronal cultures subjected to oxygen/glucose deprivation. Reactive oxygen species, lactate, phosphoenolpyruvate (PEP; a gluconeogenic product), mRNA, and protein of total PCK, PCK-1, and PCK-2 increased after MCAO and oxygen-glucose deprivation (OGD). Oxaloacetate (a gluconeogenic substrate) decreased, while PEP and glucose were increased, suggesting reactive gluconeogenesis. These changes were attenuated by phenothiazine, 3-MPA, or PCK shRNA. PCK-1 and -2 existed primarily in neurons, while the effects of ischemic stroke on the PCK expression were seen predominately in astrocytes. Thus, phenothiazine reduced infarction and oxidative/lactic stress by inhibiting PCKs, leading to functional recovery.

Indexed as

AnimalsBrainGluconeogenesisMaleNeuronsOxidative StressPhenothiazinesPhosphoenolpyruvate Carboxykinase (ATP)Picolinic AcidsRatsRats, Sprague-DawleyReactive Oxygen SpeciesStroke3-mercaptopicolinic acidphenothiazinePhenothiazinesPhosphoenolpyruvate Carboxykinase (ATP)Picolinic AcidsReactive Oxygen SpeciesGluconeogenesisIschemia/reperfusionNeuroprotectionPhenothiazine (promethazine, chlorpromazine, C+P)

Identifiers

PMID33417227
OpenAlexW3119035358

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.